Clinical Trials in Houston

Showing 7281-7300 of 13,620 trials

Assessment of a PERT-free Nutritional Therapeutic Delivery System for Cystic Fibrosis

NCT04966897

This is a single center, randomized, double-blind, cross-over trial (with a follow-on single-blind safety evaluation stage), assessing a ready-to-drink nutritional supplement used without PERT ("PERT-free"), nutritional supplement for blood lipid levels, safety and tolerability compared to a standard of care nutritional supplement used concomitantly with PERT.

Cystic FibrosisExocrine Pancreatic Insufficiency

GlycosBio, Inc.10 participantsStarted Aug 2018

Houston, Texas, United States

SUSPENDED< 1 mile

Natural History Study of MNGIE

NCT04245917

Non-interventional, prospective, multicenter, natural history study of patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)

Mitochondrial Neurogastrointestinal Encephalomyopathy

Entrada Therapeutics, Inc.60 participantsStarted Aug 2020

Aurora, Colorado, United States • New York, New York, United States • Houston, Texas, United States +2 more locations

Assessment of a PERT-free Nutritional Therapeutic Delivery System for Cystic Fibrosis

Natural History Study of MNGIE

Find Trials by Condition in Houston

Open Label Study of IV Brincidofovir in Adult Transplant Recipients With Adenovirus Viremia

A Phase 3, Long-term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia

Follow-up Study of Growth, Safety, and Efficacy of an Infant Formula for Healthy Term Infants

Are NSAIDs Effective Enough for Postoperative Pain Control After Functional Endoscopic Sinus Surgery and Septoplasty

Breast Mesh Used in Two-staged Breast Reconstruction

A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

Multivirus-specific T Cells for the Treatment of Virus Infections After Stem Cell Transplant

LVRC IDE Crossover Study (Crossover From IDE Trial CLN0009)

Treatment of Chronic Deep Vein Thrombosis (DVT) and Post-Thrombotic Syndrome (PTS) With the EkoSonic® Endovascular System

A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

Efficacy and Safety of 26-Week Treatment of AR1001 in Patients With Mild to Moderate Alzheimer's Disease

MNK6106 for Liver Disease (Hepatic Cirrhosis) That in the Past Has Affected the Brain (Hepatic Encephalopathy)

A Study to Understand the Genetics and Clinical Course of Focal Segmental Glomerulosclerosis (FSGS), Treatment-Resistant Minimal Change Disease (TR-MCD), and Diabetic Nephropathy (DN)

Phase 2/3 Study of IGSC, 20% in PIDD

Folate Receptor Alpha Peptide Vaccine With GM-CSF in Patients With Triple Negative Breast Cancer

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ABBV-3373 in Participants With Moderate to Severe Rheumatoid Arthritis (RA)

A Phase 2, to Evaluating the Safety and Efficacy of Pridopidine Vs Placebo for Symptomatic Treatment in Patients With Huntington's Disease

A Phase II Study of PDC-1421 Capsule to Evaluate the Safety and Efficacy in Patients With Major Depressive Disorder